Henning U, Wolf W P, Holtzhauer M
Institute of Biochemistry and Molecular Physiology, University of Potsdam, Berlin, Germany.
Mol Cell Biochem. 1996 Jul-Aug;160-161:41-6. doi: 10.1007/BF00240029.
Primary cardiac cell cultures of newborn rats containing approximately 50% (by cell number) spontaneously contracting cardiomyocytes were used to study the role of protein N-glycosylation for the binding of dihydropyridine (DHP) to the voltage-dependent L-type calcium channel. This binding is not influenced by the accompanying non-muscle cells. Exposure of the cells up to 6 micrograms/ml of the N-glycosylation inhibitor tunicamycin for a 44 h period resulted in a decrease of the specific DHP binding sites (Bmax) to 46.0 +/- 17.2% of the untreated control. Similar effects were observed after enzymatic deglycosylation using N-glycosidase F (PNGase F). The results suggest that a posttranslational modification of parts of the cardiac L-type Ca+2 channel by N-glycosylation is an important determinant for the binding of Ca+2 antagonists of the DHP-type to the alpha 1 subunit which itself is not glycosylated. The results suggest a participation of N glycosylation in the assembling of the subunits to the functional channel and/or its turnover. However, a possible effect of tunicamycin on the expression of the Ca channel as an alternative mechanism cannot be excluded.
使用新生大鼠的原代心脏细胞培养物(其中约50%(按细胞数量计)为自发收缩的心肌细胞)来研究蛋白质N-糖基化在二氢吡啶(DHP)与电压依赖性L型钙通道结合中的作用。这种结合不受伴随的非肌肉细胞影响。将细胞暴露于高达6微克/毫升的N-糖基化抑制剂衣霉素中44小时,导致特异性DHP结合位点(Bmax)降至未处理对照的46.0 +/- 17.2%。使用N-糖苷酶F(PNGase F)进行酶促去糖基化后也观察到类似效果。结果表明,通过N-糖基化对心脏L型Ca+2通道部分进行的翻译后修饰是DHP型Ca+2拮抗剂与本身未糖基化的α1亚基结合的重要决定因素。结果表明N-糖基化参与亚基组装成功能性通道和/或其周转。然而,不能排除衣霉素对钙通道表达作为一种替代机制的可能影响。